Tango Therapeutics (TNGX) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.36
-0.19
-0.03
0.14

Details

Expected EPS
-0.3137
Actual EPS
-0.32
Surprise EPS
-0.01
Surprise Percent
-2.01%

Description

⁨Tango Therapeutics⁩ (⁦TNGX⁩) has reported earnings of ⁦-0.32⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts